Dr. Neil Love

Oncology Today with Dr Neil Love

Science EN ↓ 553 episodi

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Visita il sito del podcast e sostieni chi lo crea: www.researchtopractice.com

Autore

Dr. Neil Love

Categoria

Science

Sito del podcast

www.researchtopractice.com

Ultimo episodio

20 nov 2026

Dove ascoltare?

I podcast nell'app Replaio Radio In arrivo

I podcast stanno per arrivare nell'app. Installala ora e scopri per primo un modo tutto nuovo di vivere i podcast

Scaricala su Google Play Installala gratis Android 10 mln+ di download · valutazione 4,7+ iOS in arrivo

Episodi

GPRC5D-Directed Therapies for Multiple Myeloma — An Interview with Prof Rakesh Popat 20.11.2026

Featuring an interview with Prof Rakesh Popat, including the following topics: Overview of GPRC5D and its clinical significance (0:00) Key findings from Phase II TALisman study regarding dysgeusia assessment for patients receiving talquetamab (2:30) Mitigating dysgeusia and dry mouth arising from GPRC5D-directed therapy (6:25) Key findings from the Phase III MonumenTAL-3 study (11:49) Selection fa...

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab 16.11.2026

Featuring an interview with Dr Matthew Lunning, including the following topics: Tafasitamab for follicular lymphoma (0:00) frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51) CME information and select publications

Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies 13.11.2026

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics: Introduction (0:00) Prologue: Saturday Night Fever (1:35) Baby Boomers' Guide to Mechanisms of Action (3:07) Second-Line Treatment (12:36) Complications Associated with Bispecific Antibodies (23:41) Case Presentations (25:52) New Bispecific T-Cell Engagers — Surovatamig (26:24) Other Novel Agents (50...

Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute 11.11.2026

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46) Bispecific Antibodies — Dr Lonial (19:16) Antibody-Drug Conjugates — Dr Richardson (37:08) Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:...

Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute 10.11.2026

Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics: Introduction: ESMO 2026; Recent FDA Approvals (0:00) Selection of Endocrine Therapy — Dr Antonarakis (2:24) Utility of PARP Inhibitors — Dr Agarwal (22:59) AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42) Radiopharmaceuticals — Dr Agarwal (45:02) CME information and select...

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute 09.11.2026

Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics: Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00) ER-Positive Breast Cancer (5:01) HER2-Positive Breast Cancer (1:19:08) Triple-Negative Breast Cancer (1:48:54) CME information and select publications

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens 06.11.2026

Featuring an interview with Dr Matthew Lunning, including the following topics: Bispecific antibody/antibody-drug conjugate combinations (0:00) A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07) CME information and select publications

Diffuse Large B-Cell Lymphoma — A Grand Rounds Program 04.11.2026

Featuring a presentation by Dr Matthew Matasar, including the following topics: Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00) Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41) Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01) Clinician Survey Results Regardi...

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis 02.11.2026

Featuring an interview with Dr Matthew Lunning, including the following topics: A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP — Ann LaCasce, MD, MMSc (0:00) CNS prophylaxis in non-Hodgkin lymphoma (7:58) CME information and select publications

Hormone Receptor-Positive Localized Breast Cancer — A Grand Rounds Activity 29.10.2026

Featuring an interview with Dr Erica Mayer, including the following topics: Risk Assessment and Genomic Assays for Hormone Receptor (HR)-Positive, HER2-Negative Localized Breast Cancer (0:00) Investigator Survey Results on Risk Assessment and Genomic Assays (20:07) Adjuvant CDK4/6 Inhibitors for High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (24:30) Investigator Survey Results on Ad...

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6 28.10.2026

Featuring perspectives from Dr Lindsey Roeker, including the following topics: Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive marrow infiltration receives first-line venetoclax/obinutuzumab and experiences an excellent response (0:00) Case: A man in his late 70s with small lymphocytic lymphoma (SLL) and cardiovascular comorbidities requiring verapam...

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 5 28.10.2026

Featuring perspectives from Dr Lindsey Roeker, including the following topics: Consensus Approach to optimizing front-line treatment (0:00) Emerging role of sonrotoclax (8:39) Bruton tyrosine kinase inhibitor monotherapy for older patients; discontinuation (14:48) Evolving role of minimal residual disease assessment (19:16) CME information and select publications

Ovarian Cancer — Microlearning Activity 4: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer 27.10.2026

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her early 70s with endometrioid carcinoma of the ovary and a large solitary brain metastasis after primary debulking surgery and adjuvant carboplatin/paclitaxel — Professor Jonathan A Ledermann (0:00) CME...

Ovarian Cancer — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer 26.10.2026

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her late 60s with a germline BRCA2 mutation and heavily pretreated ovarian cancer receives weekly nab paclitaxel and relacorilant — Angeles Alvarez Secord, MD, MHSc (0:00) CME information and select publi...

Prostate Cancer — An Interview with Prof Karim Fizazi 23.10.2026

Featuring an interview with Prof Karim Fizazi, including the following topics: Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00) Mechanism of action of opevesostat and potential role in castration-resistant prostate cancer with androgen receptor mutations (15:37) Perspectives on alpha- and beta-emit...

Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4 23.10.2026

Featuring perspectives from Prof Susana Banerjee, including the following topics: Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with response, asymptomatic creatine phosphokinase elevation and mild facial rash — Dr Stover (0:00) Case: A woman in her early 30s with recurrent metastatic low-grade...

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3 22.10.2026

Featuring perspectives from Prof Susana Banerjee, including the following topics: Overview of the biology and treatment of low-grade serous ovarian cancer (0:00) Mechanism of action of avutometinib/defactinib (10:16) RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian cancer (14:32) Ongoing clinical trials in low-grade serous ovarian cancer (27:57) CME information and sel...

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome 21.10.2026

Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics: Introduction and Overview of Bispecific Antibodies in the Clinic (0:00) Current and Future Role of Bispecific Antibodies in Non-Hodgkin Lymphoma — Dr Kamdar (15:58) Case: A man in his ea...

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies 17.10.2026

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III HARMONi-6 study; ongoing Phase III HARMONi-3 study (5:12) Key findings from the Phase III HARMONi-2 stud...

Chronic Lymphocytic Leukemia — Microlearning Activity 2 16.10.2026

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (0:00) Role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy for relaps...

Chronic Lymphocytic Leukemia — Microlearning Activity 1 15.10.2026

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor therapy in CLL; minimal residual disease and disease monitoring (4:10) Ongoing Phase III trials of BTK in...

Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer 14.10.2026

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her mid 50s with BRCA1-mutated recurrent ovarian cancer receives mirvetuximab soravtansine — Ursula Matulonis, MD (0:00) CME information and select publications

Ovarian Cancer — Microlearning Activity 1: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer 13.10.2026

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her early 50s with a germline BRCA1 mutation and ovarian cancer experiences disease recurrence after completing olaparib/bevacizumab maintenance therapy — Professor Jonathan A Ledermann (0:00) CME informa...

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting 12.10.2026

Featuring perspectives from Dr Meletios-Athanasios (Thanos) C Dimopoulos, Dr Robert Z Orlowski and Dr Noopur Raje, moderated by Dr Orlowski, including the following topics: Introduction (0:00) New and Emerging Strategies with Bispecific Antibodies in Multiple Myeloma (MM) — Dr Raje (2:20) Utility of Antibody-Drug Conjugates for Relapsed/Refractory (R/R) MM — Dr Orlowski (23:33) Potential Role of C...

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney 10.10.2026

Featuring perspectives from Dr Sara M Tolaney, including the following topics: Management of adverse events associated with TROP2-targeting antibody-drug conjugates (0:00) Managing brain metastases in triple-negative breast cancer (6:30) EGFR x HER3-directed bispecific antibodies for metastatic triple-negative breast cancer (mTNBC) (9:11) PD-1/PD-L1 x VEGF-directed bispecific antibodies for mTNBC...

Ascolta il podcast Oncology Today with Dr Neil Love su Replaio

Radio e podcast in un'unica app - gratis e senza registrazione. Installala oggi e non perderti il lancio

Scaricala su Google Play

Replaio non è un editore di podcast; i nomi dei programmi, le copertine e l'audio appartengono ai rispettivi autori e vengono distribuiti tramite feed RSS pubblici